Literature DB >> 16379028

Normal HLA class I, II, and MICA gene distribution in uveal melanoma.

J A W Metzelaar-Blok1, H M H Hurks, A Naipal, P De Lange, J E E Keunen, F H J Claas, I I N Doxiadis, M J Jager.   

Abstract

PURPOSE: The molecules of the HLA class I and II molecules as well as the MHC class I chain-related gene A (MICA), a polymorphic and stress-induced cell surface molecule, are involved in T-cell and natural killer-cell (NK-cell) mediated immune responses. In this study we looked for any genetic susceptibility contributed by HLA class I, class II, or MICA genes with regard to the development of uveal melanoma.
METHODS: Between 1998 and 2001, 159 uveal melanoma patients were typed for HLA class I and II, and 168 uveal melanoma patients were evaluated for MICA by microsatellite typing. The HLA antigen and MICA allele frequencies were compared with control groups of, respectively, 2,440 and 247 healthy Dutch individuals.
RESULTS: HLA class I, HLA class II, and MICA gene frequencies in uveal melanoma patients and healthy Dutch controls showed no significant deviations after correction for the number of comparisons.
CONCLUSIONS: We conclude that there is no genetic susceptibility or increased risk attributed to any HLA class I, class II, and MICA polymorphism with regard to the development of uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16379028

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  4 in total

1.  MICA polymorphisms and cancer risk: a meta-analysis.

Authors:  Mengyao Ji; Jun Wang; Lei Yuan; Yunting Zhang; Jixiang Zhang; Weiguo Dong; Xiulan Peng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Genetics of primary intraocular tumors.

Authors:  Nisha Nagarkatti-Gude; Yujuan Wang; Mohammad Javed Ali; Santosh G Honavar; Martine J Jager; Chi-Chao Chan
Journal:  Ocul Immunol Inflamm       Date:  2012-08       Impact factor: 3.070

3.  MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain.

Authors:  José Antonio Campillo; Ruth López-Hernández; Helios Martínez-Banaclocha; José Miguel Bolarín; Lourdes Gimeno; Anna Mrowiec; Manuela López; Beatriz Las Heras; Alfredo Minguela; Maria Rosa Moya-Quiles; Isabel Legáz; José Francisco Frías-Iniesta; Ana María García-Alonso; María Rocío Álvarez-López; Jorge Antonio Martínez-Escribano; Manuel Muro
Journal:  Dis Markers       Date:  2015-03-09       Impact factor: 3.434

Review 4.  HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.

Authors:  Zahra Souri; Annemijn P A Wierenga; Arend Mulder; Aart G Jochemsen; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.